Switzerland continues to hold its own as a focal point for innovation and discovery in global medical science and ranks very highly on the radar of both Big Pharma and the international biotech community alike. As well as Switzerland’s continuing relevance to the European…
Switzerland, long held up as an innovation powerhouse able to hold its own against the considerably larger neighbouring life science markets of France and Germany, has, in some respects, found the going tougher of late. The country’s domestic drug market has been enduring…
This report offers companies, investors, policymakers, and stakeholders crucial insight into Switzerland; a country located at the heart of Europe, home to some of the world’s most important international health institutions as well as two of its largest pharmaceutical…
This report offers companies, investors, policymakers, and stakeholders crucial insight into Switzerland; a country located at the heart of Europe, home to some of the world’s most important international health institutions as well as two of its largest pharmaceutical…
This report offers companies, investors, policymakers, and stakeholders crucial insight into Switzerland; a country located at the heart of Europe, home to some of the world’s most important international health institutions as well as two of its largest pharmaceutical…